SS Innovations International, Inc. (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system will be featured at the 2026 Society of Robotic Surgery Annual Meeting, scheduled for July 23-26 in Hollywood, Florida. The system will be displayed throughout the event and highlighted in multiple breakout sessions, including a live broadcast of a remote partial nephrectomy performed by Dr. Amitabh Singh from the company’s headquarters in Gurugram, India, on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi.
Chairman and CEO Dr. Sudhir Srivastava will participate as a speaker and panelist in several sessions covering telesurgery, robotic surgery adoption, regulatory frameworks, and global access to robotic care. As of July 6, 2026, the SSi Mantra system had been used in 12,375 procedures spanning more than 170 procedure types, including 653 cardiac procedures, 178 telesurgeries, and 225 pediatric surgeries. Approximately 2,100 physicians have been trained on the platform.
The SSi Mantra system is part of SS Innovations’ mission to make robotic surgery affordable and accessible globally. The company plans to expand the presence of its cost-effective surgical robotic solutions, which include the SSi Mudra instruments supporting various procedures. For more details, visit the full press release at https://ibn.fm/YYYKE.
This announcement underscores the growing adoption of telesurgery and robotic surgery worldwide, with implications for patients in underserved regions who may gain access to advanced surgical care. The live broadcast of a remote nephrectomy demonstrates the potential for surgeons to operate across distances, reducing the need for patient travel and expanding the reach of specialized expertise.
For investors, the milestone of over 12,000 procedures and 2,100 trained physicians indicates strong clinical adoption and training infrastructure, which could drive further growth. The company’s focus on affordability may also position it to capture market share in emerging economies where cost barriers have limited robotic surgery adoption.
